6.
Metzidie E, Manolis E, Pournaras S, Sofianou D, Tsakris A
. Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates. J Antimicrob Chemother. 2005; 57(1):158-60.
DOI: 10.1093/jac/dki427.
View
7.
Rice L, Carias L, Rudin S, Lakticova V, Wood A, Hutton-Thomas R
. Enterococcus faecium low-affinity pbp5 is a transferable determinant. Antimicrob Agents Chemother. 2005; 49(12):5007-12.
PMC: 1315957.
DOI: 10.1128/AAC.49.12.5007-5012.2005.
View
8.
Draghi D, Sheehan D, Hogan P, Sahm D
. In vitro activity of linezolid against key gram-positive organisms isolated in the united states: results of the LEADER 2004 surveillance program. Antimicrob Agents Chemother. 2005; 49(12):5024-32.
PMC: 1315934.
DOI: 10.1128/AAC.49.12.5024-5032.2005.
View
9.
Murray B, Foster S, Brunton J, Harford P
. In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin. J Clin Invest. 1986; 77(1):289-93.
PMC: 423338.
DOI: 10.1172/JCI112289.
View
10.
Mutnick A, Biedenbach D, Turnidge J, Jones R
. Spectrum and potency evaluation of a new oxazolidinone, linezolid: report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis. 2002; 43(1):65-73.
DOI: 10.1016/s0732-8893(02)00371-1.
View
11.
Zorzi W, Zhou X, Dardenne O, Lamotte J, Raze D, Pierre J
. Structure of the low-affinity penicillin-binding protein 5 PBP5fm in wild-type and highly penicillin-resistant strains of Enterococcus faecium. J Bacteriol. 1996; 178(16):4948-57.
PMC: 178279.
DOI: 10.1128/jb.178.16.4948-4957.1996.
View
12.
Costa Y, Galimand M, Leclercq R, Duval J, Courvalin P
. Characterization of the chromosomal aac(6')-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother. 1993; 37(9):1896-903.
PMC: 188089.
DOI: 10.1128/AAC.37.9.1896.
View
13.
Lewis 2nd J, Owens A, Cadena J, Sabol K, Patterson J, Jorgensen J
. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother. 2005; 49(4):1664-5.
PMC: 1068653.
DOI: 10.1128/AAC.49.4.1664-1665.2005.
View
14.
Rhinehart E, Smith N, WENNERSTEN C, Gorss E, Freeman J, Eliopoulos G
. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990; 323(26):1814-8.
DOI: 10.1056/NEJM199012273232606.
View
15.
Mainardi J, Fourgeaud M, Hugonnet J, Dubost L, Brouard J, Ouazzani J
. A novel peptidoglycan cross-linking enzyme for a beta-lactam-resistant transpeptidation pathway. J Biol Chem. 2005; 280(46):38146-52.
DOI: 10.1074/jbc.M507384200.
View
16.
Zirakzadeh A, Patel R
. Epidemiology and mechanisms of glycopeptide resistance in enterococci. Curr Opin Infect Dis. 2005; 18(6):507-12.
DOI: 10.1097/01.qco.0000186849.54040.2a.
View
17.
Noble W, Virani Z, Cree R
. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992; 72(2):195-8.
DOI: 10.1016/0378-1097(92)90528-v.
View
18.
McDonald J, Engemann J, Kaye K, Sexton D
. Co-infection or co-colonization with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a network of community hospitals. Infect Control Hosp Epidemiol. 2004; 25(8):622.
DOI: 10.1086/503504.
View
19.
Munoz-Price L, Lolans K, Quinn J
. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection. Clin Infect Dis. 2005; 41(4):565-6.
DOI: 10.1086/432121.
View
20.
Markowitz S, Wells V, Williams D, Stuart C, Coudron P, Wong E
. Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis. Antimicrob Agents Chemother. 1991; 35(6):1075-80.
PMC: 284289.
DOI: 10.1128/AAC.35.6.1075.
View